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 The past decade has witnessed several 
paradigmatic shift s in our understanding 
of acute kidney disease. Th e fi rst was the 
recognition that even small decrements in 
kidney function impacted clinical out-
comes. For example, Chertow and collea-
gues demonstrated that increases in serum 
creatinine of as little as 0.3  mg / dl were 
associated with an increase in in-hospital 
mortality of 80 % . 1 As a result, there has 
been a shift  in nomenclature away from a 
primary focus on organ failure (acute renal 
failure) to a focus on lesser degrees of organ 
injury (acute kidney injury) and the deve-
lopment of new defi nitions and staging 
systems to describe acute kidney injury. 2,3 
 Th e second paradigmatic change was the 
recognition of the important interplay 
between acute kidney injury (AKI) and 
chronic kidney disease (CKD). While it 
was well recognized that patients with CKD 
are predisposed to the development of AKI, 
previous teaching held that the majority of 
patients who survived an episode of AKI 
recovered kidney function. Although it was 
known that a small percentage of patients 
surviving an episode of AKI might be left  
with chronic renal impairment, the renal 
prognosis for the vast majority of patients 
surviving an episode of AKI was generally 
believed to be good. As recently as 2005, an 
epidemiologic surveillance study reported 
that  ‘ although the majority of patients with 
(severe acute renal failure) will die, most 
survivors will become independent from 
renal replacement therapy within a year, ’ 
but it was silent about the level of kidney 
function. 4 More recently, however, multiple 
studies have highlighted the interplay 
among AKI, progressive CKD, and longer-
term morta lity risk. 5 – 9 
 In one of the fi rst analyses linking AKI to 
progression of CKD, Ishani and colleagues 
used a 5 % random sample of US Medicare 
benefi ciary claims data linked to the end-
stage renal disease (ESRD) incidence data-
base from the US Renal Data System. 5 Th ey 
found that in hospitalized patients older 
than 67 years, AKI was associated with a 
nearly sevenfold increase in the hazard of 
developing ESRD during the ensuing 2 years 
in comparison with patients who did not 
develop AKI. When stratifi ed on the basis 
of preexisting CKD, acute-on-chronic kid-
ney disease was associated with a 41-fold 
increase in the hazard of ESRD,  de novo AKI 
with a 13-fold increase, and CKD in the 
absence of AKI with a nearly 8.5-fold 
increase in comparison with patients with-
out either acute or chronic kidney disease. 
AKI was also associated with a 2.4-fold 
increased hazard of death. 
 Lo and colleagues evaluated the risk of 
progressive CKD in a cohort of 556,090 
adult patients with baseline estimated 
glomerular fi ltration rates (eGFRs) of at 
least 45  ml / min per 1.73  m 2 who were 
hospita lized in Kaiser Permanente of North-
ern California Health System over an 8-year 
period. 6 Patients who had dialysis-requiring 
AKI but were dialysis-independent 30 days 
aft er hospital discharge had a 28-fold higher 
risk of having an eGFR less than 30  ml / min 
per 1.73  m 2 as compared with patients who 
did not have dialysis-requiring AKI. Dialy-
sis-requiring AKI was also associated with 
a more than twofold increased risk of death. 
Similarly, using administrative databases 
from the Canadian province of Ontario, 
Wald and colleagues found an incidence 
rate of ESRD of 26.3 per 1000 person-years 
among 3769 people who survived an epi-
sode of AKI requiring dialysis and were 
dialysis-independent 30 days aft er hospital 
discharge as compared with an incidence of 
9.1 per 1000 person-years among 13,598 
matched controls who did not have AKI, for 
an adjusted hazard ratio of 3.2. 7 Unlike in 
the prior study, however, Wald and col-
leagues did not observe an increase in long-
term mortality risk associated with AKI. 
 Two additional studies used data from 
the US Department of Veterans Aff airs 
Healthcare System to assess the impact 
of AKI on long-term mortality and pro-
gression of CKD. 8,9 Lafrance and Miller 
identified 82,711 patients with non-
dialysis-requiring AKI among 864,933 
hospitalized patients. 8 In this cohort, the 
adjusted mortality risk in patients with 
AKI who survived at least 90 days 
aft er hospital discharge was approximately 
40 % higher than that in patients without 
AKI. In addition, there was a graded 
relationship between mortality risk and 
severity of AKI. In a separate analysis, 
Chawla and colleagues observed a mark-
edly increased risk of development of 
advanced CKD (eGFR   <  30  ml / min per 
1.73  m 2 ) in patients with a baseline eGFR 
greater than 60  ml / min per 1.73  m 2 who 
were hospitalized with AKI as compared 
with patients without AKI who were hos-
pitalized for pneumonia or myocardial 
infarction. 9 Risk factors for development 
of CKD included a diagnosis of acute 
tubular necrosis (as compared with other 
etio logies of AKI), need for renal replace-
ment therapy, severity of AKI (graded on 
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 Although older teaching suggested that patients who survived an 
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the basis of maximal increase in serum 
creatinine), serum albumin, and age. 
 Extending these lines of investigation, 
Bucaloiu and colleagues 10 (this issue) 
analyze the impact of AKI on mortality 
and on progressive kidney disease in a 
cohort of patients with no evidence of 
preexisting CKD. In contrast to the earlier 
studies, however, they limit their analysis to 
patients who manifested complete recovery 
of kidney function on the basis of return 
of the eGFR to within 90 % of the baseline 
value within 90 days. Patients with 
AKI were then matched, by the use of a 
propensity score for the deve lopment of 
AKI, with up to three contemporaneous 
controls. Of an initial cohort of 39,477 
people, 1997 patients met the criteria for 
recovered AKI; 1610 of these AKI patients 
were able to be propensity-matched with 
3652 control patients. During a median fol-
low-up of slightly more than 3 years, the 
mortality rate was approximately 50 % 
higher in patients who had AKI than in 
patients without AKI (2.8 deaths per 1000 
patient-years vs. 1.9 deaths per 1000 
patient-years). Th e risk of  de novo CKD was 
increased more than twofold in the AKI 
cohort (incident rate of 28.1 per 1000 
patient-years vs. 13.1 per 1000 patient-
years). When incident CKD was added to 
the Cox proportional hazard model for 
mortality, the hazard ratio was attenuated 
from 1.50 (95 % confi dence interval, 1.21 –
 1.85;  P  =  0.0002) to 1.18 (95 % confi dence 
interval, 0.95 – 1.46;  P  =  0.13). Thus, the 
authors suggest that the increased mortality 
risk following an episode of AKI is medi-
ated by the development of CKD rather 
than the AKI event itself ( Figure 1a ). Th is 
conclusion is further suggested by the 
observation that mortality rates in patients 
with and without AKI who did not develop 
CKD were similar, while the mortality rate 
in patients with AKI who subsequently 
developed CKD was 3.6-fold greater. 
 Th is elegant analysis by Bucaloiu and col-
leagues 10 represents the fi rst demonstration 
that even in patients who manifest virtually 
complete recovery of kidney function, AKI 
is associated with a subsequent increased 
risk for development of CKD. However, 
several limitations must be considered in 
interpreting these findings. First, the 
authors were unable to propensity-match 
all of the AKI patients with non-AKI con-
trols. Th e unmatched AKI patients repre-
sented a substantially diff erent cohort — they 
were older, had a higher burden of comor-
bidities, were more likely to require critical 
care, and had longer hospitalization. Th us, 
the extrapolation of the study results to 
these patients must be undertaken with 
caution; however, this unmatched cohort 
was even more likely to develop CKD. 
Second, despite the careful propensity-
score matching that was used, as with any 
observational study, there remains a risk of 
residual confounding and bias. In addition, 
because of reliance on non-protocolized 
laboratory testing, there is a further 
risk that bias may have been introduced. 
Finally, it is important to recognize that 
observational associations cannot confi rm 
causality. Th e authors identify numerous 
predictors of  de novo CKD, including 
increasing age, lower baseline eGFR, bur-
den of comorbidities, hypertension, heart 
failure, hypoalbuminemia, and severity of 
AKI. With the exception of severity of AKI, 
these are also risk factors for the develop-
ment of AKI. Th us, it remains possible that 
AKI is only a marker and not the mediator 
of the development of CKD ( Figure 1b ). 
 Whether marker or mediator, these 
results reinforce the need for follow-up 
nephrologic care for patients who sustain 
an episode of AKI, even if they have virtu-
ally complete return to baseline kidney 
function. Much as we understand the risk 
of acute-on-chronic kidney disease, we 
must now recognize that the relationship 
is bidirectional and that our patients 
with AKI are at risk for chronic-on-acute 
kidney disease. 
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 Figure 1  |  Schematic representation of relationship among patient risk factors, development 
of AKI and  de novo CKD after AKI, and mortality. ( a ) Model suggested by Bucaloiu and 
colleagues: 10 Risk factors predispose to the development of AKI; the development of AKI mediates 
to the development of subsequent CKD, which increases mortality risk. ( b ) Alternative model: Risk 
factors for the development of AKI are also risk factors for the subsequent development of CKD 
and mortality. In this model, AKI may be either a direct mediator for the development of CKD and 
mortality risk or only a marker of risk. Similarly, development of CKD may be a mediator or only 
a marker of mortality risk. 
